Stockreport

Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September

Dianthus Therapeutics, Inc.  (DNTH) 
PDF NEW YORK and WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advanci [Read more]